Get the Stockscreener App
23.50
0.13%
0.03
After Hours:
24.56
1.06
+4.51%
Beta Bionics Inc stock is traded at $23.50, with a volume of 226.72K.
It is up +0.13% in the last 24 hours and up +0.00% over the past month.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product include the iLet Bionic Pancreas (iLet). The Company operates as single segment, focused on the development, manufacture and sale of the iLet.
See More
Previous Close:
$23.47
Open:
$23.02
24h Volume:
226.72K
Relative Volume:
5.82
Market Cap:
$1.01B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$23.01
$24.36
1-Week Range:
$21.71
$24.36
52-Week Range:
$21.71
$24.36
Beta Bionics Inc Stock (BBNX) Company Profile
Compare BBNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
23.50 | 1.01B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
129.07 | 224.12B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.28 | 155.19B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.40 | 149.44B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.01 | 114.86B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.34 | 41.68B | 6.60B | 4.16B | 490.10M | 6.93 |
Beta Bionics Inc Stock (BBNX) Latest News
Eventide Asset Management, LLC Acquires Significant Stake in Bet - GuruFocus.com
Artificial Pancreas Maker Beta Bionics Just Started Trading. Should You Buy BBNX Stock After Its IPO? - Barchart
Beta Bionics: A Sugar Rush For This IPO (NASDAQ:BBNX) - Seeking Alpha
Signals Recap: Ozempic's Latest Approval, EKDA on Reddit, Lilly Stops Relaxin, Beta Bionics IPO, NKF Turns 75, & More... - substack.com
Obesity-drug maker Metsera posts largest gain as IPOs defy market swoon - MSN
Beta Bionics Announces Closing of $234.6 Million Initial - GlobeNewswire
BBNXBeta Bionics, Inc. Latest Stock News & Market Updates - StockTitan
Oil company Infinity Natural Resources debuts IPO amid deregulation push - MSN
4 Firms Guide Pair Of Biotech IPOs Raising $415M Combined - Law360
Beta Bionics raises $204M in IPO - MedTech Dive
Beta Bionics stock opens 29% higher in Nasdaq debut - MSN
Beta Bionics (BBNX) Opens At $22, IPO Priced At $17 By Investing.com - Investing.com Canada
Beta Bionics Goes Public After Raising $204M Upsized Offering - Orange County Business Journal
Bionics Upsized $204M IPO: A Game-Changer for Diabetes Treatment - USA Herald
Beta Bionics raises $204m to kickstart medtech IPO season - Medical Device Network
Beta Bionics Shares Rise in Nasdaq Debut -January 30, 2025 at 12:39 pm EST - Marketscreener.com
Cooley, Latham Steer Beta Bionics' Upsized $204M IPO - Law360
Beta Bionics Rings the Opening Bell - Nasdaq
Insulin delivery device maker Beta Bionics prices further upsized IPO at $17, the high end of the upwardly revised range - Renaissance Capital
Artificial pancreas maker Beta Bionics aims to raise $204M in Nasdaq IPO - MSN
Beta Bionics Set to Revolutionize Diabetes Management with $204 Million IPO! - mivalle.net.ar
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering - GlobeNewswire
Beta Bionics sets terms for upsized $165M IPO - MSN
Beta Bionics sets terms for upsized $165M IPO (BBNX:Pending) - Seeking Alpha
Beta Bionics targets $695 million valuation in upsized US IPO - MSN
BBNX IPO NewsInsulin delivery device maker Beta Bionics increases deal size by 47% ahead of $165 million IPO - Renaissance Capital
IPO Roundup: Smithfield Foods, Beta Bionics and more - MSN
Obesity-Focused Metsera Leads Biotech Firms Eyeing IPOs - Law360
Beta Bionics targets $114M IPO raise to fund insulin pump development - MedTech Dive
Beta Bionics, Inc. (BBNX) Announces January 30th IPO - Defense World
Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing - MSN
Beta Bionics Targets $113 Million in IPO, Plans Nasdaq Listing - GuruFocus.com
Beta Bionics sets terms for upsized $113M IPO - MSN
S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail
Beta Bionics Announces Plans for IPO - Orange County Business Journal
Beta Bionics Aims For IPO To Cover Heavy Losses (BBNX) - Seeking Alpha
Beta Bionics, maker of ‘bionic pancreas,’ files for IPO - MedTech Dive
Oilfield Services Firm Flowco Set to Drill Down On $392M IPO - Law360
Beta Bionics Files Registration Statement for Proposed Initial Public Offering - GlobeNewswire
Beta Bionics Raises $60M Series E - Orange County Business Journal
Beta Bionics Announces Closing of a $60 Million Series E Financing - Newswire
Diabetes Dialogue: Diabetes Tech Updates in October 2024 - MD Magazine
Beta Bionics Announces Launch of the iLet Bionic Pancreas With Abbott’s FreeStyle Libre 3 Plus Sensor - Newswire
Abbott expands pump partnerships, launches Lingo CGM - BioWorld Online
Beta Bionics Announces Partnership With Abbott to Integrate the iLet Bionic Pancreas With the FreeStyle Libre 3 Plus iCGM - Yahoo Finance
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics - Business Wire
Beta Bionics’ iLet bionic pancreas launches worldwide - Medical Device Network
First AID positions Dexcom for healthy new year - BioWorld Online
Beta Bionics Announces iLet Bionic Pancreas Is Now Added to the Express Scripts National Commercial Formularies - Newswire
Beta Bionics Secures $100M in Series D - MPO-mag
Beta Bionics closes $100M Series D to support bionic pancreas - Drug Delivery Business News
Beta Bionics Inc Stock (BBNX) Financials Data
There is no financial data for Beta Bionics Inc (BBNX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Beta Bionics Inc Stock (BBNX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Mensinger Mike | Chief Product Officer |
Jan 31 '25 |
Sale |
17.00 |
13 |
221 |
25,669 |
| Wellington Hadley Harbor Aggre | 10% Owner |
Jan 31 '25 |
Buy |
17.00 |
1,000,000 |
17,000,000 |
3,901,599 |
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):